T1	Intervention 17 39	penbutolol and placebo
T2	Intervention 229 337	40 mg of the beta-blocker penbutolol (Betapressin TM; Hoechst Ltd., Frankfurt/Main) in comparison to placebo
T3	Intervention 477 614	penbutolol and placebo for a period of three days, and then were examined with the help of the glucose-controlled insulin infusion system
T4	Intervention 713 734	penbutolol or placebo
